Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | SVP, Human Resources | February 28, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date February 28, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 277,945 |
Ending reported balance
After 2026-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-28 · Exercise / conversion · Acquired 27,697 · Balance 149,343 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 2 · 2026-02-28 · Exercise / conversion · Acquired 52,316 · Balance 201,659 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 3 · 2026-02-28 · Exercise / conversion · Acquired 144,393 · Balance 346,052 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 4 · 2026-02-28 · Tax withholding · Disposed 68,107 · Balance 277,945 F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-28 · Exercise / conversion · Disposed 27,697 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 52,317 |
Reported balance
After 2026-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-28 · Exercise / conversion · Disposed 52,316 · Balance 52,317 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 288,787 |
Reported balance
After 2026-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-02-28 · Exercise / conversion · Disposed 144,393 · Balance 288,787 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2026 Filed Mar 3, 2026 12:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 144,393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000041 · form4.xml · derivative · entry 7 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,787 Underlying: Common Stock · 144,393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 52,316 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000041 · form4.xml · derivative · entry 6 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,317 Underlying: Common Stock · 52,316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 27,697 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000041 · form4.xml · derivative · entry 5 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,697 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 68,107 | $1.47 | $100,117.29 |
DisclosureSEC source: 0001062822-26-000041 · form4.xml · nonDerivative · entry 4 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,945 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 144,393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000041 · form4.xml · nonDerivative · entry 3 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 52,316 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000041 · form4.xml · nonDerivative · entry 2 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 27,697 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000041 · form4.xml · nonDerivative · entry 1 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 375,300 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000026 · form4.xml · derivative · entry 2 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,300 Underlying: Common Stock · 375,300 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 250,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000026 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,200 Underlying: Common Stock · 250,200 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 52,317 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007538 · form4.xml · derivative · entry 7 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,633 Underlying: Common Stock · 52,317 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 27,696 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007538 · form4.xml · derivative · entry 6 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,697 Underlying: Common Stock · 27,696 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 18,943 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007538 · form4.xml · derivative · entry 5 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,943 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 30,004 | $0.67 | $20,102.68 |
DisclosureSEC source: 0001127602-25-007538 · form4.xml · nonDerivative · entry 4 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,646 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 52,317 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007538 · form4.xml · nonDerivative · entry 3 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 27,696 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007538 · form4.xml · nonDerivative · entry 2 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 18,943 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007538 · form4.xml · nonDerivative · entry 1 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 433,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005223 · form4.xml · derivative · entry 2 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,180 Underlying: Common Stock · 433,180 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 649,780 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005223 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 649,780 Underlying: Common Stock · 649,780 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:31 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 27,697 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007625 · form4.xml · derivative · entry 5 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,393 Underlying: Common Stock · 27,697 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:31 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 18,944 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007625 · form4.xml · derivative · entry 4 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,943 Underlying: Common Stock · 18,944 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:31 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 22,425 | $2.62 | $58,753.50 |
DisclosureSEC source: 0001127602-24-007625 · form4.xml · nonDerivative · entry 3 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,694 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:31 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 27,697 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007625 · form4.xml · nonDerivative · entry 2 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:31 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 18,944 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007625 · form4.xml · nonDerivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 156,950 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004468 · form4.xml · derivative · entry 2 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,950 Underlying: Common Stock · 156,950 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 156,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004468 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,950 Underlying: Common Stock · 156,950 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 20:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 6,000 | $1.84 | $11,040.00 |
DisclosureSEC source: 0001127602-23-022118 · form4.xml · nonDerivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,478 Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 20:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 10,000 | $2.43 | $24,300.00 |
DisclosureSEC source: 0001127602-23-019443 · form4.xml · nonDerivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,478 Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:54 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 18,943 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007930 · form4.xml · derivative · entry 3 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,887 Underlying: Common Stock · 18,943 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:54 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 6,465 | $2.17 | $14,029.05 |
DisclosureSEC source: 0001127602-23-007930 · form4.xml · nonDerivative · entry 2 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,478 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:54 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 18,943 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007930 · form4.xml · nonDerivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 249,280 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004941 · form4.xml · derivative · entry 2 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,280 Underlying: Common Stock · 249,280 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 83,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004941 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,090 Underlying: Common Stock · 83,090 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 56,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004769 · form4.xml · derivative · entry 2 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,830 Underlying: Common Stock · 56,830 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 170,500 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004769 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,500 Underlying: Common Stock · 170,500 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:34 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 85,185 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001127602-22-000731 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,185 Underlying: Common Stock · 85,185 shares Expires 2032-01-03 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (1/3/2023) and vests 1/48th per month for each month of service thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.